NCT03349411

Brief Summary

The goal of this study is to understand what brain mechanisms become disrupted when stroke survivors experience delirium. Delirium is an acute reduction in attention and cognition, associated with poor recovery, longer hospitalization and even death. One major factor increasing the risk of delirium after stroke may be spatial neglect occurring after stroke on the right side of the brain. Spatial neglect affects awareness, orientation, and movement. The study will test the hypothesis that the right-dominant brain networks for arousal and attention are affected in both of these disorders. It is expected that the activity and structural integrity of these brain networks will correlate with behavioral signs and severity of delirium and spatial neglect. To test this hypothesis, the study will measure spatial neglect and delirium symptoms in 45 acute (NYC Health + Hospitals/Bellevue ) and 30 subacute (Kessler Institute for Rehabilitation) stroke survivors and evaluate brain scans for these participants. This study may contribute to knowledge about brain bio-markers of delirium, which will greatly aid in delirium detection in stroke and other disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2017

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 18, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 21, 2017

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

April 30, 2021

Status Verified

April 1, 2021

Enrollment Period

3.5 years

First QC Date

November 17, 2017

Last Update Submit

April 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • fMRI

    functional connectivity

    within 1 week of study enrollment

Secondary Outcomes (3)

  • Confusion Assessment Method - Severity

    within 1 week of enrollment

  • Diffusion MRI

    within 1 week of study enrollment

  • structural MRI

    within 1 month of enrollment

Study Arms (2)

Acute Ischemic Stroke Sample

45 acute patients with first ever ischemic stroke on the right side of the brain will be recruited at NYC Health + Hospitals/Bellevue . They will undergo testing with the Confusion Assessment Method (CAM), Behavioral Inattention Test (BIT), Montreal Cognitive Assessment (MOCA) and Geriatric Depression Scale (GDS)

Diagnostic Test: Confusion Assessment MethodDiagnostic Test: Behavioral Inattention TestDiagnostic Test: Montreal Cognitive AssessmentDiagnostic Test: Geriatric Depression Scale

Subacute Ischemic Stroke Sample

30 patients with first ever ischemic stroke on the right side of the brain who are within 3 months of their stroke will be recruited at Kessler Institute for Rehabilitation. They will undergo testing with the Confusion Assessment Method (CAM), Behavioral Inattention Test (BIT), Florida Mental Status Examination (FMSE); Kessler Foundation Neglect Assessment Process (KF-NAP); and Geriatric Depression Scale (GDS). These participants will also complete a research Magnetic Resonance Imaging (MRI) scan.

Diagnostic Test: Confusion Assessment MethodDiagnostic Test: Behavioral Inattention TestDiagnostic Test: Magnetic Resonance ImagingDiagnostic Test: Florida Mental Status ExaminationDiagnostic Test: Geriatric Depression ScaleDiagnostic Test: Kessler Foundation Neglect Assessment Process

Interventions

This test is used for delirium assessment. The CAM consists of a series of questions, measuring attention (digits forward and backwards, days of the week and months of the year backwards), orientation (person, place, time), memory (immediate and delayed recall of 3 concrete nouns); and probing for any sleep, perceptual, or thinking disturbances. It was designed to incorporate DSM-III criteria for delirium.

Also known as: CAM-S
Acute Ischemic Stroke SampleSubacute Ischemic Stroke Sample

This test is used for neglect assessment. The BIT consists of 6 tasks: figure and shape copying; line, star, and letter cancellation, and representational drawing. Such tasks were shown to be appropriate in patients within 48 hours of stroke onset. Scoring of each test will include proportion of error responses on each test or deviation from midpoint on line bisection. Figure and shape copying and representational drawing will be scored based on each item completed.

Also known as: BIT
Acute Ischemic Stroke SampleSubacute Ischemic Stroke Sample

Structural, functional and diffusion weighted scans will be obtained or acquired, depending on the cohort. Subacute sample participants will undergo a research MRI scan, whereas acute sample participants will allow the release of their clinical MRI scans.

Also known as: MRI
Subacute Ischemic Stroke Sample

This test is used for mental status assessment, and it will be conducted in our subacute sample only. The FMSE tests memory, attention, language, visuospatial processing, and executive function. It will help to establish patients' mental status profile, including any deficits.

Also known as: FMSE
Subacute Ischemic Stroke Sample

MoCA is a brief cognitive screening tool for individuals with mild cognitive impairment and will be used in the acute sample.

Also known as: MOCA (basic test)
Acute Ischemic Stroke Sample

Because depression has been previously associated with delirium, patients will be evaluated for depression with the GDS. The GDS is a self-report measure consisting of 30 yes/no questions to measure depression in the elderly. It will be used as a covariate in data analysis.

Also known as: GDS
Acute Ischemic Stroke SampleSubacute Ischemic Stroke Sample

This is a 10-category scale for spatial neglect based on observation of activities of daily living (e.g., eating, dressing, grooming, gaze orientation). Thee test is based on the Catherine Bergego Scale (CBS) and administered via the standardized KF-Neglect Assessment Process developed within our program.

Also known as: KF-NAP
Subacute Ischemic Stroke Sample

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This is a prospective observational study using a consecutive patient sample. The study will be carried out at 2 sites: NYC Health + Hospitals/Bellevue and Kessler Institute for Rehabilitation. 1st ever ischemic stroke patients will be approached for interest in participation. Patients of both sexes whose stroke event is on the right side of the brain and who qualify for the study based on the inclusion and exclusion criteria will be recruited.

You may qualify if:

  • \- Able to give informed consent prior to beginning of testing; have 1st ever ischemic stroke on the right side of the brain; speaks English; \>18 years of age

You may not qualify if:

  • all of the following will be excluded:
  • Participants with another brain disorder expected to produce severe visual-spatial abnormalities (including malignant brain tumor, traumatic brain injury with post-injury neurological problems, or Alzheimer's Disease)
  • Women knowing themselves to be pregnant will not be enrolled; pregnancy may itself affect visual-spatial attention. However, women of childbearing potential will not be tested for pregnancy before participating.
  • Persons consuming more than 10 alcoholic beverages weekly
  • For participants who will undergo an MRI scan the following will be excluded:
  • Pacemaker or other implanted electrical device incompatible with the MR environment
  • Eye injury to the eye involving metal filings
  • Unable to undergo MRI due to doctor recommendation
  • Claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kessler Foundation

West Orange, New Jersey, 07052, United States

Location

NYC Health + Hospitals/Bellevue

New York, New York, 10016, United States

Location

Related Publications (2)

  • Boukrina O, Barrett AM. Disruption of the ascending arousal system and cortical attention networks in post-stroke delirium and spatial neglect. Neurosci Biobehav Rev. 2017 Dec;83:1-10. doi: 10.1016/j.neubiorev.2017.09.024. Epub 2017 Sep 27.

  • Boukrina O, Kowalczyk M, Koush Y, Kong Y, Barrett AM. Brain Network Dysfunction in Poststroke Delirium and Spatial Neglect: An fMRI Study. Stroke. 2022 Mar;53(3):930-938. doi: 10.1161/STROKEAHA.121.035733. Epub 2021 Oct 8.

MeSH Terms

Conditions

StrokeDelirium

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesConfusionNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Olga Boukrina, Ph.D.

    Kessler Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

November 17, 2017

First Posted

November 21, 2017

Study Start

July 18, 2017

Primary Completion

December 30, 2020

Study Completion

December 30, 2020

Last Updated

April 30, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will share

Some of the data collected during this project must be publicly shared no later than 1 year from the date of project completion. The purpose of data sharing is to allow other scientists to independently verify study results.

Shared Documents
STUDY PROTOCOL
Time Frame
Anticipated 6/30/2021, de-identified data will be stored indefinitely
Access Criteria
Factual data (including raw data and metadata, such as study design, description of tests, and how they were conducted) will be made freely and publicly available via the Open Science Framework. Users will need to register on the website to access data.
More information

Locations